The Anderson Perspective

A broad coalition urges Congress to pass new legislation addressing the long-term impact of blast exposure on veterans, aiming to curb alarming rates of mental health struggles and suicide.

A bipartisan bill seeks to uncover why veterans face a significantly higher ALS risk, aiming to drive research, improve care, and protect future service members.

A policy reversal at the Small Business Administration has cleared a backlog of veteran certification applications, but sparks debate over federal contracting priorities and the balance between DEI initiatives.

A new report reveals a concerning increase in melanoma diagnoses among U.S. military personnel and veterans, highlighting unique risk factors and a growing need for targeted research and prevention efforts.

The Department of Veterans Affairs is strengthening its fight against antibiotic resistance through a new partnership with Bitscopic and the appointment of a leading infectious disease expert to spearhead adoption of its PraediAlert platform.

A $50 billion federal program is incentivizing states to expand the role of Physician Associates, potentially unlocking critical access to care in underserved rural communities. But the path isn’t without hurdles.

A legal battle in Arkansas over pharmacy benefit manager ownership is raising critical questions about vertical integration, drug pricing, and access to care. Will other states follow suit?

A $1.6 million investment is expanding the Equity Rx program, providing critical access to prescription medications for uninsured and underinsured patients across seven states. The initiative aims to improve health equity and reduce disparities.

NextPlat Corp. is expanding its healthcare footprint through PharmcoRx, partnering with a virtual provider to fill prescriptions for weight loss, hormone therapy, and addiction treatment. The deal signals a broader trend in telehealth.

Soaring prescription drug prices, especially for specialty medications, are putting immense pressure on employers. A growing number are turning to consultants to navigate the complex world of pharmacy benefit managers and regain control of healthcare spending.

ARS Pharmaceuticals is challenging the epinephrine auto-injector status quo with its nasal spray and new program offering virtual consultations and potential $0 co-pay. This innovative approach seeks to improve access and convenience for allergy sufferers.

A new interactive map reveals the alarming rise of 'pharmacy deserts' across the U.S., disproportionately impacting rural and low-income communities. What’s driving this trend and what can be done?

New tech-enabled service, VantaStat, bypasses ER delays and lengthy waits by connecting patients directly with orthopedic specialists, potentially reshaping urgent MSK care in the DMV.

Levitate’s attainment of HIPAA compliance positions it to deliver personalized marketing solutions to dental and chiropractic practices, addressing a growing demand for patient-centric care and data privacy.

A new ecosystem combining peritoneal dialysis with remote monitoring and data analytics aims to address low adoption rates of home dialysis, promising improved patient outcomes and reduced healthcare costs.

A new ranking system from U.S. News & World Report aims to bring much-needed transparency to the rapidly growing home healthcare market, where millions rely on post-hospitalization care.

The FDA has authorized Pulsenmore’s home-use prenatal ultrasound device, potentially revolutionizing access to care for expectant mothers in underserved areas and reshaping the future of prenatal monitoring.

Sigrid Therapeutics is shifting its sales strategy, moving from direct-to-consumer to a physician-led model in the US. The company hopes its clinically-backed 'Glucose Stabiliser' will gain traction in a crowded market.

Breakthrough cancer treatment recognized for impact, but accessibility remains a concern as researchers explore potential beyond oncology. A look at the future of personalized medicine.

Abbott's AVEIR DR system, the first dual-chamber leadless pacemaker, is poised to transform cardiac care, offering patients greater freedom, reduced complications, and a new lease on life. The technology is challenging existing market dynamics.